Stockreport

Krystal Biotech Touts Positive KB407 CF Gene Therapy Data, Eyes Repeat Dosing and Registrational Path [Yahoo! Finance]

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors
PDF post-dose — exceeding the company's ~5–15% transduction target and including positive results in Class I ("null") mutation patients. Krystal plans to move rapidly into [Read more]